Tyrphostins are inhibitors of guanylyl and adenylyl cyclases
- PMID: 15209521
- DOI: 10.1021/bi036234n
Tyrphostins are inhibitors of guanylyl and adenylyl cyclases
Abstract
Guanylyl cyclase C (GC-C), the receptor for guanylin, uroguanylin, and the heat-stable enterotoxin, regulates fluid balance in the intestine and extraintestinal tissues. The receptor has an extracellular domain, a single transmembrane spanning domain, and an intracellular domain that harbors a region homologous to protein kinases, followed by the C-terminal guanylyl cyclase domain. Adenine nucleotides can regulate the guanylyl cyclase activity of GC-C by binding to the intracellular kinase homology domain (KHD). In this study, we have tested the effect of several protein kinase inhibitors on GC-C activity and find that the tyrphostins, known to be tyrosine kinase inhibitors, could inhibit GC-C activity in vitro. Tyrphostin A25 (AG82) was the most potent inhibitor with an IC(50) of approximately 15 microM. The mechanism of inhibition was found to be noncompetitive with respect to both the substrate MnGTP and the metal cofactor. Interestingly, the activity of the catalytic domain of GC-C (lacking the KHD) expressed in insect cells was also inhibited by tyrphostin A25 with an IC(50) of approximately 5 microM. As with the full-length receptor, inhibition was found to be noncompetitive with respect to MnGTP. Inhibition was reversible, ruling out a covalent modification of the receptor. Structurally similar proteins such as the soluble guanylyl cyclase and the adenylyl cyclases were also inhibited by tyrphostin A25. Evaluation of a number of tyrphostins allowed us to identify the requirement of two vicinal hydroxyl groups in the tyrphostin for effective inhibition of cyclase activity. Therefore, our studies are the first to report that nucleotide cyclases are inhibited by tyrphostins and suggest that novel inhibitors based on the tyrphostin scaffold can be developed, which could aid in a greater understanding of nucleotide cyclase structure and function.
Similar articles
-
Biochemical and pharmacological characterization of P-site inhibitors on homodimeric guanylyl cyclase domain from natriuretic peptide receptor-A.Biochem Pharmacol. 2007 Apr 1;73(7):954-63. doi: 10.1016/j.bcp.2006.12.008. Epub 2006 Dec 10. Biochem Pharmacol. 2007. PMID: 17196175
-
The kinase homology domain of receptor guanylyl cyclase C: ATP binding and identification of an adenine nucleotide sensitive site.Biochemistry. 2006 Feb 14;45(6):1888-98. doi: 10.1021/bi052089x. Biochemistry. 2006. PMID: 16460035
-
Design and characterization of a soluble fragment of the extracellular ligand-binding domain of the peptide hormone receptor guanylyl cyclase-C.Protein Eng Des Sel. 2009 Jan;22(1):1-7. doi: 10.1093/protein/gzn062. Epub 2008 Nov 5. Protein Eng Des Sel. 2009. PMID: 18987130
-
Recognition and signal transduction mechanism of Escherichia coli heat-stable enterotoxin and its receptor, guanylate cyclase C.J Pept Res. 2005 Feb;65(2):261-71. doi: 10.1111/j.1399-3011.2005.00218.x. J Pept Res. 2005. PMID: 15705168 Review.
-
E. coli heat-stable enterotoxin and guanylyl cyclase C: new functions and unsuspected actions.Trans Am Clin Climatol Assoc. 2003;114:67-85; discussion 85-6. Trans Am Clin Climatol Assoc. 2003. PMID: 12813912 Free PMC article. Review.
Cited by
-
Interactions of methoxyacetic acid with androgen receptor.Toxicol Appl Pharmacol. 2009 Jul 15;238(2):101-10. doi: 10.1016/j.taap.2008.03.015. Epub 2008 Apr 7. Toxicol Appl Pharmacol. 2009. PMID: 18486176 Free PMC article.
-
Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.J Med Chem. 2009 Aug 27;52(16):4981-5004. doi: 10.1021/jm9002395. J Med Chem. 2009. PMID: 19610618 Free PMC article. Review. No abstract available.
-
The pseudokinase domain in receptor guanylyl cyclases.Methods Enzymol. 2022;667:535-574. doi: 10.1016/bs.mie.2022.03.046. Epub 2022 Apr 18. Methods Enzymol. 2022. PMID: 35525553 Free PMC article. Review.
-
The effect of erythropoietin on normal and neoplastic cells.Biologics. 2012;6:163-89. doi: 10.2147/BTT.S32281. Epub 2012 Jun 27. Biologics. 2012. PMID: 22848149 Free PMC article.
-
Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells.Clin Exp Metastasis. 2008;25(3):225-31. doi: 10.1007/s10585-007-9136-0. Epub 2007 Dec 11. Clin Exp Metastasis. 2008. PMID: 18071911
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous